Dupilumab and Conjunctivitis: Demographic, Clinical, and Treatment Variables Included in Propensity Score Matching

Published: 2 November 2026| Version 1 | DOI: 10.17632/44dzrwfmjk.1
Contributor:
Mike Povelaitis

Description

Demographic, diagnostic, medication, and other covariates used for propensity score matching. Codes are provided where applicable. The same matching variables were applied across dupilumab-exposed and unexposed comparisons.

Files

Categories

Conjunctivitis

Licence